DIO3OS and osteosarcoma: These outcomes suggested that the expression levels of DIO3OS in osteosarcoma were lower than lipomatous neoplasms (p < 0.001), myomatous neoplasms (p < 0.01), and synovial-like neoplasms (p < 0.001) (Fig. 5A).